📢 Have your say by 24 November.
Your responses will directly inform the new IMP-ACT Risk Assessment Tool, to be previewed at our free webinar on 8 December.Â
We invite academics, health service teams, investigators, and university spin-offs/start-ups to complete the anonymous Project IMP-ACT national benchmark survey.
Who We Need to Hear From:
We are gathering insights from all stakeholders involved in IMP handling, preparation, and clinical trial compliance:
Principal Investigators & Academic Research Leads
University Spin-off & Biotech Founders
Clinical Trials Unit (CTU) Managers & Directors
Project Managers & Trial Coordinators
Research Office Leads & Technology Transfer Managers
Human Research Ethics Committee (HREC) Secretariats & Chairs
Research Governance Officers (RGOs)
Participation Note:
The survey is 100% anonymous, captures aggregated trends only, and takes just 5 minutes to complete.
After completing the survey, you’ll be offered a separate link to register your interest in the roundtable or webinar. Your survey answers remain anonymous.Â